YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Browse Top Headlines

Search Text
Start Date
End Date

23andMe Gets $1.4m from NIH, Publishes Parkinson's Research

| Bio-IT World | 23andMe announced this morning a two-year grant of almost $1.4 million from the National Institutes of Health to expand development of the company’s database and research engine, and its participation in a large-scale GWAS study of Parkinson's disease.

Cloud Weakness Exploited to Launch DDoS Attacks

| Computerworld | Attackers can target Amazon EC2 instances by exploiting a vulnerability in distributed search engine software, Computerworld is reporting. Researchers have found new variants of a Trojan program for Linux that launches denial-of-service (DDoS) attacks running on EC2 instances.

Testing an Accelerated Path for Biosimilars

| Bio-IT World News Brief | For the first time, the FDA has accepted an application for a generic version of a biologic drug under the new regulatory pathway established by the Biologics Price Competition and Innovation Act of 2010.

Cypher Genomics Signs Deal with Illumina, Expands Executive Team

| Bio-IT World News Brief | Cypher Genomics yesterday announced a sales deal with Illumina and added a host of new players to executive board positions.

With $650 Million Gift, Psychiatric Disorders Once Again in Limelight at the Broad

| Bio-IT World | Ted Stanley, the philanthropist whose 2007 gift of $100 million formed the basis of the Stanley Center for Psychiatric Research at the Broad Institute, has pledged an additional $650 million to the center.

Behind the knoSYS 100: Building the Genome Supercomputer

| Bio-IT World Contributed Commentary | In the fall of 2012, when Knome launched the knoSYS 100 “genome supercomputer”, the company envisioned that every next-generation sequencing platform would one day sit alongside an analysis and interpretation engine. Silicon Mechanics stepped in to make that vision a reality.

Roche Planning to Stay Out of Acquisitions

| Reuters | Roche is staying out of the pharma merger and acquisition fray, the CEO said. "We're sticking to our previous strategy... [of] small acquisitions and partnerships."

Berry Genomics, Illumina Seek Chinese Regulatory Approval for NIPT

| Bio-IT World News Brief | Berry Genomics has chosen Illumina next-generation sequencing (NGS) technology as the platform on which Berry hopes to secure Chinese Food and Drug Administration (CFDA) regulatory approval for clinical applications. The combined "system" is in late stage CFDA testing, the Chinese company says.

Universal Language: The Pistoia Alliance Takes on Indescribable Biology

| Bio-IT World | The Pistoia Alliance received a Best Practices Award at this year's Bio-IT World Conference & Expo for its work on HELM, a project that establishes a standard notation for complex macromolecules that are too large to sketch out atomically, but too heterogeneous to express as chains of RNA or amino acids. The project will aid interoperability across the industry, as pharma companies increasingly rely on strange, hybrid biochemistry in creating new therapeutics.

Could CRISPR Transform Wild Ecosystems?

| Bio-IT World | In a paper published yesterday in the open access journal eLife, George Church and colleagues discuss the potential for "gene drives" that alter the genomes of whole wild populations using CRISPR gene editing technology, and weigh the risks and public interests surrounding such initiatives.

Illumina Acquires Regulatory Strategy Consulting Firm

| Bio-IT World News Brief | Illumina today announced its acquisition of Myraqa, a consulting firm specializing in the regulatory strategy surrounding in vitro diagnostics, particularly companion diagnostics.

Novartis Signs On to License Google's Glucose-Monitoring Contact Lenses

| New York Times | Google and Novartis have announced a partnership for Novartis to license Google's smart contact lens that could measure a wearer's blood sugar levels.

IBM Gains Ground with SoftLayer Cloud

| Computerworld | IBM is gaining cloud ground with its SoftLayer product, Big Blue says, reporting 6,000 new customers in the last year and $1.2 billion invested in data centers.

Transcriptic Launches Molecular, Cell Biology On-Demand Lab

| Bio-IT World News Brief | Transcriptic today launched the Transcriptic Platform, their own cloud-based programmable system for defining and executing experimental protocols. The company says the platform can create a 10-fold productivity advantage for researchers working on molecular and cell biology.

BGI Scientists Expand Reference Genes for Human Microbiome

| Bio-IT World | The Beijing Genomics Institute (BGI), China's gene sequencing powerhouse, has released a set of reference genes for the human gut microbiome, in a catalogue that is substantially larger and covers a greater diversity of human populations than any previous resources.

Illumina Chosen as Service Provider for Genomics England Project

| Technology Review | Illumina has been chosen as the "preferred partner" for the UK's 100,000 genomes project. Genomics England chose Illumina to do the sequencing, and said that fewer than five other companies bid for the job.

Peer Inside the American Gut

| Bio-IT World News Brief | This Wednesday, American Gut, the crowdsourced project that has now sequenced gut microbiota samples from over 3,000 volunteers, released both a round of results and its own analytical pipeline.

Human Brain Project Responds to Complaints

| Bio-IT World | Today, the leadership of the Human Brain Project circulated a document responding to this Monday's open letter to the European Commission, in which neuroscientists aired concerns about the aims and decision-making processes behind the HBP.

AWS Summit Kicks Off in New York, Features Best of Show Winner

| Bio-IT World News Brief | The Amazon Web Services Cloud Summit kicked off with a keynote from Werner Vogels, Chief Technology Officer. Vogels announced CloudWatch Logs to monitor the system and application logs for trends and events over time, and highlighted the work of the Novartis Institutes for Biomedical Research using a 2014 Bio-IT World Best of Show winner.

Scripps Calls off USC Merger or Acquisition Discussions

| U-T San Diego | The rumored merger of the Scripps Research Institute in La Jolla and the University of Southern California is off, the Scripps board of trustees said yesterday
 1        


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.